Show Summary Details
Page of

Issues in the Prevention of Malaria Among Women at War 

Issues in the Prevention of Malaria Among Women at War
Chapter:
Issues in the Prevention of Malaria Among Women at War
Author(s):

Remington L. Nevin

DOI:
10.1093/med/9780199344536.003.0006
Page of

PRINTED FROM OXFORD MEDICINE ONLINE (www.oxfordmedicine.com). © Oxford University Press, 2016. All Rights Reserved. Under the terms of the licence agreement, an individual user may print out a PDF of a single chapter of a title in Oxford Medicine Online for personal use (for details see Privacy Policy and Legal Notice).

date: 15 December 2018

The changing roles of women at war may now place them at significant risk of contracting malaria. As with men, prevention of malaria among women rests on interruption of disease transmission through the avoidance of mosquito bites, supplemented where appropriate by use of prophylactic antimalarial medications. Women at war may face unique challenges in bite avoidance, and may face greater health risks than men from currently deployed antimalarials, many of which lack direct reproductive safety data. In this chapter, strategies for prevention are presented, including complications in implementing avoidance measures in deployed settings. Pharmacokinetics, pharmacodynamics, patterns of adverse effects, and compliance are discussed. The chapter presents important considerations for antimalarial prophylaxis appropriate for deploying female servicemembers; considerations for forgoing prophylaxis in certain settings and circumstances; options for early malaria diagnosis and treatment; and considerations for medical evacuation of women in deployed settings who remain at high risk of malaria.

Access to the complete content on Oxford Medicine Online requires a subscription or purchase. Public users are able to search the site and view the abstracts for each book and chapter without a subscription.

Please subscribe or login to access full text content.

If you have purchased a print title that contains an access token, please see the token for information about how to register your code.

For questions on access or troubleshooting, please check our FAQs, and if you can't find the answer there, please contact us.